Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$517M |
| 2 |
NXP Semiconductors
NXPI
|
+$351M |
| 3 |
Oracle
ORCL
|
+$279M |
| 4 |
Palo Alto Networks
PANW
|
+$268M |
| 5 |
Boston Scientific
BSX
|
+$204M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERN
Cerner Corp
CERN
|
+$517M |
| 2 |
ExxonMobil
XOM
|
+$385M |
| 3 |
Cenovus Energy
CVE
|
+$292M |
| 4 |
PLAN
Anaplan, Inc.
PLAN
|
+$236M |
| 5 |
Phillips 66
PSX
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.76% |
| 2 | Financials | 7.66% |
| 3 | Healthcare | 7.12% |
| 4 | Industrials | 5.11% |
| 5 | Consumer Discretionary | 4.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Lennar Class A
LEN
$21.2B
| $74.6M | 0.05% |
1,092,598
+156,337
| +17% | +$11.5M |
|
427
CALL
Cigna
CI
$74.1B
| $74.6M | 0.05% |
283,100
-5,600
| -2% | -$1.44M |
|
428
AMN Healthcare
AMN
$1.34B
| $74.6M | 0.05% |
679,773
-210,374
| -24% | -$20.8M |
|
429
C.H. Robinson
CHRW
$16.7B
| $74.2M | 0.05% |
732,306
-100,437
| -12% | -$10.5M |
|
430
CALL
State Street SPDR S&P Regional Banking ETF
KRE
$4.06B
| $74.2M | 0.05% |
1,277,900
+607,200
| +91% | +$37.9M |
|
431
GSK
GSK
$104B
| $73.7M | 0.05% |
1,355,002
+470,648
| +53% | +$26M |
|
432
Canadian Imperial Bank of Commerce
CM
$105B
| $73.6M | 0.05% |
1,516,414
+1,154,968
| +320% | +$62.9M |
|
433
CALL
Texas Instruments
TXN
$236B
| $73.5M | 0.05% |
478,300
+313,400
| +190% | +$52.7M |
|
434
T. Rowe Price
TROW
$24B
| $73.4M | 0.05% |
646,171
+632,761
| +4,719% | +$80.4M |
|
435
Copart
CPRT
$30.8B
| $73.3M | 0.05% |
2,699,016
+2,062,916
| +324% | +$58.7M |
|
436
PUT
Amgen
AMGN
$240B
| $73.3M | 0.05% |
301,300
-174,500
| -37% | -$42.8M |
|
437
PUT
Booking.com
BKNG
$160B
| $73.3M | 0.05% |
1,047,500
+82,500
| +9% | +$7.04M |
|
438
Equinix
EQIX
$104B
| $73.1M | 0.05% |
111,252
+101,059
| +991% | +$70M |
|
439
Ally Financial
ALLY
$12.9B
| $72.6M | 0.05% |
2,166,946
+710,268
| +49% | +$28.4M |
|
440
Eaton
ETN
$159B
| $72.6M | 0.05% |
576,048
+553,736
| +2,482% | +$77.5M |
|
|
WCN
441
Waste Connections
WCN
$42.5B
| $72.3M | 0.04% |
583,267
-73,314
| -11% | -$9.51M |
|
442
DexCom
DXCM
$34.4B
| $72.2M | 0.04% |
968,833
+63,065
| +7% | +$5.76M |
|
443
Synopsys
SNPS
$75.5B
| $71.8M | 0.04% |
236,510
-96,334
| -29% | -$29.1M |
|
444
Fortive
FTV
$18.3B
| $71.8M | 0.04% |
1,752,232
-494,595
| -22% | -$21.9M |
|
445
Franco-Nevada
FNV
$52.1B
| $71.2M | 0.04% |
541,492
+146,232
| +37% | +$21.6M |
|
446
Nutrien
NTR
$35.5B
| $71.2M | 0.04% |
894,060
-261,375
| -23% | -$25.4M |
|
447
PUT
Marathon Petroleum
MPC
$102B
| $71.2M | 0.04% |
865,600
+400
| +0% | +$37.4K |
|
448
MSCI
MSCI
$41.5B
| $71.1M | 0.04% |
172,431
-29,905
| -15% | -$13M |
|
449
Monster Beverage
MNST
$95.8B
| $70.9M | 0.04% |
3,059,292
-1,362,908
| -31% | -$29.6M |
|
450
PUT
Mondelez International
MDLZ
$82.6B
| $70.9M | 0.04% |
1,141,800
+1,024,000
| +869% | +$64.7M |
|
Similar funds
Israel Englander's Q2 2022 Portfolio in Review
As of Q2 2022, Israel Englander held 7,971 positions worth $161B, down 15% from $189B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Israel Englander deployed $7.94B of net new capital in Q2 2022, opening 1,144 new positions and adding to 2,588 existing holdings. Its largest new stake was M&T Bank: 828,809 shares worth $132M.
By sector, the portfolio is most concentrated in Technology at 7.8% of assets, up from 7.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was ExxonMobil, an estimated $385M trimmed.
- Israel Englander's largest Q2 2022 buy was M&T Bank: 828,809 shares worth $132M.
- Israel Englander added most to Invesco QQQ Trust in Q2 2022, an estimated $517M increase.
- Israel Englander's biggest Q2 2022 reduction was ExxonMobil, cutting an estimated $385M.
- Israel Englander fully exited Cerner Corp in Q2 2022, selling an estimated $517M.
- Israel Englander's ten largest holdings make up 23% of its $161B portfolio in Q2 2022.
- Israel Englander opened 1,144 new positions and closed 1,065 in Q2 2022.
- Israel Englander's portfolio value fell 15% quarter-over-quarter to $161B.
Based on Millennium Management's 13F filing for Q2 2022, filed 15 Aug 2022.